CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
We cut our price target by $4 to $439, 71x our FY 27 (Jan.) EPS view. We raise our FY 27 EPS estimate by $0.27 to $6.18 and our FY 28 view by $0.14 to $7.39. MDB's Q1 came in modestly better than expected, with another strong bookings quarter driving RPO growth up by an impressive 88% Y/Y to $1.46B. AI volumes continue to accelerate but remain a small part of the overall business, with core enterprise workloads delivering the beat and modest guidance raise (MDB now expects 24% sales growth vs. a prior 22% view). We expect 2026 to be a significant scaling year for agentic workloads, and we continue to think investors are underestimating MDB's potential to see growth accelerate as it gains traction with AI natives and existing Fortune 500 customers evolve their AI offerings. We think Q1's results were a decent print that did enough to convince investors that FY 26's deceleration relates more to conservatism than AI competition/existentialism that has rocked the software space this year.